The independent source for health policy research, polling, and news.
781-800 of 1,312 results
A pricing tool embedded in their electronic health record and prescribing system lets doctors see how much patients will pay out-of-pocket based on their insurance and the pharmacy. But doctors have been slow to adopt the technology, which has limitations.
KHN, in collaboration with PBS NewsHour, reports on the skyrocketing cost of insulin — and the trend's deadly consequences. The price in the U.S. nearly doubled from 2012 to 2016, prompting some patients and activists to travel to Canada, where insulin can be 90% cheaper.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
A draft plan spearheaded by House Speaker Nancy Pelosi would allow the federal government for the first time to negotiate prices for 250 drugs for Medicare and apply those prices to all payers, including employers and insurers.
Colorado, Florida and Vermont — with the support of President Donald Trump — are exploring plans to bring drugs across the border from Canada to help lower costs.
Democratic presidential candidates disagreed on how to fix health care in their first debate Wednesday, although they all called for boosting insurance coverage and lowering prices. Meanwhile, the Trump administration is keeping health care in the news, too, with a new plan to make medical prices more available to the public. Stephanie Armour of The Wall Street Journal, Rebecca Adams of CQ Roll Call and Anna Edney of Bloomberg News join KHN’s Julie Rovner to discuss this, plus the latest in news about bipartisan progress on catch-all legislation to address “surprise” medical bills. Plus, Rovner interviews NPR’s Jon Hamilton about the latest KHN-NPR “Bill of the Month” installment.
Independent black-owned pharmacies fill a void for African American patients looking for care that’s sensitive to their heritage, beliefs and values.
Beware at the pharmacy counter: Your insurance company could be in cahoots with a pharmacy benefit manager — and the negotiations that go on between them are trade secrets.
Guess who’s back grabbing headlines? Pharmacy benefit managers — those companies that serve as middlemen in the prescription drug pipeline.
Julie Rovner, the chief Washington correspondent for Kaiser Health News, joins Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and Alan Weil of Health Affairs at the Aspen Ideas: Health festival to discuss how consumers’ values impact the politics surrounding the national debate on health care.
How big an issue will health really be in the 2020 election? Will the Republicans find their political footing on the issue? In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico and Margot Sanger-Katz of The New York Times report from the Aspen Ideas: Health festival in Aspen, Colo. Joining them are Chris Jennings, who advised Democratic Presidents Bill Clinton and Barack Obama on health policy, and Lanhee Chen, who advised GOP presidential candidates Mitt Romney and Marco Rubio.
A rule proposed by the Trump administration would leave patients with limited English proficiency with fewer guarantees of a written notice that free translation services are available. It also would no longer require directions on how patients can report discrimination they experience in a medical setting.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
A new data analysis by KHN and Johns Hopkins researchers shows that even as the CDC issued warnings, surgeons handed out many times the number of opioid pills needed for post-op pain.
Even as awareness of the opioid crisis grew, prescribing habits of surgeons changed very little from 2011 to 2016, found a data analysis by KHN and Johns Hopkins Bloomberg School of Public Health. Use this interactive tool to search by doctor or practicing hospital.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
In March, a chemical cousin of the anesthetic and club drug ketamine was approved for the treatment of patients with intractable depression. But critics say studies presented to the FDA provided at best modest evidence it worked and did not include information about the safety of the drug, Spravato, for long-term use.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
As states struggle to respond to the national drug crisis, officials around the country are watching Oklahoma. The state's attorney general says opioid drugmakers helped ignite a health crisis that has killed thousands of residents.
© 2026 KFF